Results 31 to 40 of about 9,731 (238)
Efficacy and safety of narrowband ultraviolet B phototherapy for prurigo nodularis: a tertiary center experience [PDF]
Anais Brasileiros de DermatologiaBackground: Prurigo nodularis is a chronic pruritic dermatosis and narrowband-UVB (NB-UVB) phototherapy is considered an effective and safe treatment option in patients with multiple comorbidities. Objective: In this study, the authors aimed to evaluate
Esra Agaoglu +3 more
doaj +1 more source
Prurigo actínico en un centro dermatológico de referencia en Colombia: 108 casos
Biomédica: revista del Instituto Nacional de Salud, 2020 Introducción. El prurigo actínico es una fotodermatosis crónica. Afecta con mayor frecuencia a la población latinoamericana, predomina en mujeres y compromete la piel expuesta al sol, las conjuntivas y los labios. Objetivo.
Andrea Carolina Pardo-Zamudio +3 more
doaj +1 more source
Prurigo crónico: actualización
Actas Dermo-Sifiliográficas, 2022 Resumen: El prurigo crónico es una entidad con una apariencia clínica común pero que puede ser secundaria a un gran número de patologías. Históricamente ha sido una enfermedad no bien definida y con escasas terapias disponibles, por lo que su manejo es ...
A. Docampo-Simón +2 more
doaj +1 more source
Apoptosis and apoptotic pathway in actinic prurigo by immunohistochemistry [PDF]
, 2015 Background: Actinic prurigo (AP) is an idiopathic photodermatosis, this entity requires exposure to UV-B and -A to develop lesions. Apoptosis is a physiological death program that can be initiated by a permanently active mechanism (extrinsic pathway ...
Cuevas González, Juan Carlos +4 more
core +2 more sources
Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review
JEADV Clinical Practice, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino +3 more
wiley +1 more source
Journal of Cutaneous Immunology and Allergy, 2023 We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.
Keiji Kosaka +3 more
doaj +1 more source
A Case of Exfoliative Vesiculobullous Prurigo Pigmentosa Cured by Doxycycline and Topical Tacrolimus
Case Reports in Dermatology, 2021 Prurigo pigmentosa is a rare inflammatory skin disease characterized by an unexpected onset of diffuse erythematous papules and macules usually on the chest, neck, and back. These generally resolve, leaving reticular hyperpigmentation.
Hoon Choi +4 more
doaj +1 more source
JEADV Clinical Practice, EarlyView.In adults with atopic dermatitis and chronic pruritus, the mental comorbidity of Somatic Symptom Disorder is associated with higher average and worst pruritus intensity, higher psychological distress and lower quality of life. Additionally, there were nonsignificant changes in cutaneous nerve fiber densities in skin biopsies.
Stefan M. Kahnert +13 more
wiley +1 more source
TARGETED THERAPY IN THE TREATMENT OF NODULAR PRURIGO
Медицинская иммунология, 2019 Pruritus is a rare chronic recurrent polyethological skin disease characterized by severe itching, resulting in the formation of skin elements such as papulo-vesicles, papules, nodules and plaques.
Natalia Shestakova +2 more
doaj +1 more source
Dupilumab for bullous pemphigoid with intractable pruritus [PDF]
, 2019 Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. Treatment regimens typically include topical and systemic immunosuppressive medications.
Eichenfield, Dawn Z +2 more
core